Optogenetic stimulation of the brainstem dorsal motor nucleus ameliorates acute pancreatitis.
acute pancreatitis
cholinergic anti-inflammatory pathway (CAP)
cytokines
dorsal motor nucleus
inflammation
vagus nerve
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2023
2023
Historique:
received:
14
02
2023
accepted:
28
03
2023
pubmed:
14
5
2023
medline:
16
5
2023
entrez:
14
5
2023
Statut:
epublish
Résumé
Inflammation is an inherently self-amplifying process, resulting in progressive tissue damage when unresolved. A brake on this positive feedback system is provided by the nervous system which has evolved to detect inflammatory signals and respond by activating anti-inflammatory processes, including the cholinergic anti-inflammatory pathway mediated by the vagus nerve. Acute pancreatitis, a common and serious condition without effective therapy, develops when acinar cell injury activates intrapancreatic inflammation. Prior study has shown that electrical stimulation of the carotid sheath, which contains the vagus nerve, boosts the endogenous anti-inflammatory response and ameliorates acute pancreatitis, but it remains unknown whether these anti-inflammatory signals originate in the brain. Here, we used optogenetics to selectively activate efferent vagus nerve fibers originating in the brainstem dorsal motor nucleus of the vagus (DMN) and evaluated the effects on caerulein-induced pancreatitis. Stimulation of the cholinergic neurons in the DMN significantly attenuates the severity of pancreatitis as indicated by reduced serum amylase, pancreatic cytokines, tissue damage, and edema. Either vagotomy or silencing cholinergic nicotinic receptor signaling by pre-administration of the antagonist mecamylamine abolishes the beneficial effects. These results provide the first evidence that efferent vagus cholinergic neurons residing in the brainstem DMN can inhibit pancreatic inflammation and implicate the cholinergic anti-inflammatory pathway as a potential therapeutic target for acute pancreatitis.
Identifiants
pubmed: 37180135
doi: 10.3389/fimmu.2023.1166212
pmc: PMC10167283
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1166212Subventions
Organisme : NIGMS NIH HHS
ID : R01 GM132672
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM128008
Pays : United States
Organisme : NIGMS NIH HHS
ID : R35 GM118182
Pays : United States
Informations de copyright
Copyright © 2023 Thompson, Tsaava, Rishi, Nadella, Mishra, Tuveson, Pavlov, Brines, Tracey and Chavan.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.